These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Timolol and acetazolamide. A study of concurrent administration. Kass MA; Korey M; Gordon M; Becker B Arch Ophthalmol; 1982 Jun; 100(6):941-2. PubMed ID: 7092633 [TBL] [Abstract][Full Text] [Related]
3. Effect of adding betaxolol to dipivefrin therapy. Weinreb RN; Ritch R; Kushner FH Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535 [TBL] [Abstract][Full Text] [Related]
4. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group. Strahlman E; Tipping R; Vogel R Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651 [TBL] [Abstract][Full Text] [Related]
5. The mechanism of betaxolol, a new ocular hypotensive agent. Reiss GR; Brubaker RF Ophthalmology; 1983 Nov; 90(11):1369-72. PubMed ID: 6664677 [TBL] [Abstract][Full Text] [Related]
6. Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure. Long DA; Johns GE; Mullen RS; Bowe RG; Alexander D; Epstein DL; Weiss MJ; Masi RJ; Charap AD; Eto CY Ophthalmology; 1988 Jun; 95(6):735-41. PubMed ID: 3062529 [TBL] [Abstract][Full Text] [Related]
7. [Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension]. Coulangeon LM; Sole M; Menerath JM; Sole P Ophtalmologie; 1990; 4(2):156-61. PubMed ID: 2235007 [TBL] [Abstract][Full Text] [Related]
8. Local ocular hypotensive effect of topically applied acetazolamide. Flach AJ; Peterson JS; Seligmann KA Am J Ophthalmol; 1984 Jul; 98(1):66-72. PubMed ID: 6742080 [TBL] [Abstract][Full Text] [Related]
9. Comparison of ocular hypotensive effects of acetazolamide and atenolol. Macdonald MJ; Gore SM; Cullen PM; Phillips CI Br J Ophthalmol; 1977 May; 61(5):345-8. PubMed ID: 326302 [TBL] [Abstract][Full Text] [Related]
10. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Maus TL; Larsson LI; McLaren JW; Brubaker RF Arch Ophthalmol; 1997 Jan; 115(1):45-9. PubMed ID: 9006424 [TBL] [Abstract][Full Text] [Related]
11. Additive effect of betaxolol and epinephrine in primary open angle glaucoma. Allen RC; Epstein DL Arch Ophthalmol; 1986 Aug; 104(8):1178-84. PubMed ID: 2874783 [TBL] [Abstract][Full Text] [Related]
12. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine. Robin AL Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691 [TBL] [Abstract][Full Text] [Related]
13. A double-masked three-month comparison between 0.25% betaxolol suspension and 0.5% betaxolol ophthalmic solution. Weinreb RN; Caldwell DR; Goode SM; Horwitz BL; Laibovitz R; Shrader CE; Stewart RH; Williams AT Am J Ophthalmol; 1990 Aug; 110(2):189-92. PubMed ID: 2198812 [TBL] [Abstract][Full Text] [Related]
14. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy. Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667 [TBL] [Abstract][Full Text] [Related]
15. Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma. Berrospi AR; Leibowitz HM Arch Ophthalmol; 1982 Jun; 100(6):943-6. PubMed ID: 6124227 [TBL] [Abstract][Full Text] [Related]
16. Decreased intraocular pressure in the hypertensive human eye with betaxolol, a beta 1-adrenergic antagonist. Feghali JG; Kaufman PL Am J Ophthalmol; 1985 Dec; 100(6):777-82. PubMed ID: 2866715 [TBL] [Abstract][Full Text] [Related]
17. Management of acute closed-angle glaucoma with miotics and timolol. Airaksinen PJ; Saari KM; Tiainen TJ; Jaanio EA Br J Ophthalmol; 1979 Dec; 63(12):822-5. PubMed ID: 526463 [TBL] [Abstract][Full Text] [Related]
18. The effects of betaxolol hydrochloride ophthalmic solution on intraocular pressures during transient microgravity. Pattinson TJ; Gibson CR; Manuel FK; Bishop SL; March WF Aviat Space Environ Med; 1999 Oct; 70(10):1012-7. PubMed ID: 10519481 [TBL] [Abstract][Full Text] [Related]
19. Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study. Piltz J; Gross R; Shin DH; Beiser JA; Dorr DA; Kass MA; Gordon MO Am J Ophthalmol; 2000 Oct; 130(4):441-53. PubMed ID: 11024416 [TBL] [Abstract][Full Text] [Related]